Riskpilot← Back to searchSign inGet full accessMedilex Oy
OYDissolvedY-tunnus 0926540-0Rauhalinnantie 23Medical specialists activities · NACE 8622Est. 19931 employees
Revenue 2024
EUR 327K
+14% vs 2023
EBITDA margin
37.8%
+2% vs 2023
Equity ratio
94.2%
Financial strength
Net profit 2024
EUR 113K
+34% vs 2023
| Revenue | EUR 327K | +14% |
| EBITDA | EUR 124K | +2% |
| Net profit | EUR 113K | +34% |
| Total assets | EUR 428K | +29% |
| Equity | EUR 403K | +28% |
| Employees | 1 | — |
Legal name
Medilex Oy
Y-tunnus number
0926540-0
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
11. toukokuuta 1993
Share capital
EUR 8 426
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on lääkäritoiminnan sekä siihen liittyvän koulutus-, tutkimus- ja julkaisutoiminnan harjoittaminen, välittäminen ja myynti. Yhtiö voi harjoittaa sijoitustoimintaa ja omistaa, myydä, hallita ja vuokrata kiinteää omaisuutta, rakennuksia, osakkeita ja arvopapereita sekä käydä näillä kauppaa.
Address
Rauhalinnantie 23
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 58 | 242 | 220 | 277 | 288 | 327 |
| Staff expenses | −7 | −53 | −47 | −46 | −52 | −59 |
| EBITDA | 35 | 122 | 90 | 127 | 121 | 124 |
| Depreciation & amort. | — | — | — | — | −2 | −1 |
| EBIT | 35 | 122 | 90 | 127 | 119 | 123 |
| Net financials | — | — | — | −34 | −1 | 11 |
| Profit before tax | 35 | 122 | 90 | 93 | 118 | 134 |
| Tax | 7 | 33 | 18 | 19 | 34 | 21 |
| Net profit | 28 | 90 | 72 | 74 | 84 | 113 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 56 | 181 | 236 | 290 | 331 | 428 |
| Equity | 42 | 132 | 193 | 252 | 316 | 403 |
| Long-term debt | — | — | — | — | 0 | 0 |
| Short-term debt | 14 | 50 | 43 | 38 | 15 | 25 |
| Total debt | 14 | 50 | 43 | 38 | 15 | 25 |
EBITDA margin
37.8%
This company
15.8%
Market median
+139% vs market
20192024
Equity ratio
94.2%
This company
38.2%
Market median
+147% vs market
20192024
Return on equity
28.0%
This company
18.4%
Market median
+52% vs market
20192024
Net profit margin
34.4%
This company
8.1%
Market median
+325% vs market
20192024
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20192024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KM Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
YS Deputy Member | Deputy Member | 2007 | — | — |
EK | Audit | 2019 | — | — |
PO Deputy Member | Deputy Member | 2019 | — | — |
AA Deputy Member | Deputy Member | 2023 | — | — |
PH Deputy auditor | Deputy auditor | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairperson | 2007 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medilex Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katri Marjaana Salmivalli | Chief Executive Officer | 0 companies |
| Yrjö Salomo Honkala | Deputy Member | 0 companies |
| Elina Katariina Niemi | Audit | 0 companies |
| Pekka Olavi Hossi | Deputy Member | 0 companies |
| Alisa Anni Katariina Salmivalli | Deputy Member | 0 companies |
| Paul Henrik Vikman | Deputy auditor | 0 companies |
| Pekko Kalervo Honkala | Chairperson | 0 companies |